Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
- DOI
- 10.1007/s40744-024-00659-0
- Published
- 2024-03-15
- Container
- Rheumatology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-024-00659-0,
title = {Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison},
author = {Richard B. Warren and Iain B. McInnes and Peter Nash and Jean-Marie Grouin and Nikos Lyris and Damon Willems and Vanessa Taieb and Jason Eells and Philip J. Mease},
year = {2024},
journal = {Rheumatology and Therapy},
doi = {10.1007/s40744-024-00659-0},
url = {https://doi.org/10.1007/s40744-024-00659-0}
}RIS
TY - JOUR TI - Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison AU - Richard B. Warren AU - Iain B. McInnes AU - Peter Nash AU - Jean-Marie Grouin AU - Nikos Lyris AU - Damon Willems AU - Vanessa Taieb AU - Jason Eells AU - Philip J. Mease PY - 2024 JO - Rheumatology and Therapy DO - 10.1007/s40744-024-00659-0 UR - https://doi.org/10.1007/s40744-024-00659-0 ER -
APA
Warren, R. B., McInnes, I. B., Nash, P., Grouin, J., Lyris, N., Willems, D., Taieb, V., Eells, J., & Mease, P. J. (2024). Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison. Rheumatology and Therapy. https://doi.org/10.1007/s40744-024-00659-0
Source records
- crossref · retrieved 2026-09-25T23:20:47.732Z